Ritamix Global Limited (1936) AI Stock Analysis

• Market Cap: HK$273.76M
• Dividend Yield: N/A
• Average Volume (3M): 42.67K
• Price to Earnings (P/E): 19.3
• Beta (1Y): 0.59
• Revenue Growth: 3.45%
• EPS Growth: -27.71%
• Country: HK
• Employees: 52
• Sector: Consumer Defensive
• Sector Strength: 61
• Industry: Agricultural Farm Products
• EPS (TTM): 0.03
• Shares Outstanding: 472,000,000
• 10 Day Avg. Volume: 2,400
• 30 Day Avg. Volume: 42,666
• PEG Ratio: -1.45
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -231.16
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 55 Neutral
• Price Target: ―

Ritamix Global Limited's stock score is influenced predominantly by its financial performance and technical indicators. The company's strong equity position and low leverage are positive, but declining profitability and cash flow volatility are significant concerns. Technically, the stock is showing bearish signs, with downward momentum and trading below key moving averages. Valuation is moderate, with a P/E ratio slightly above the industry average, but the lack of a dividend yield reduces appeal.

Ritamix Global Limited Business Overview & Revenue Model

Company Description

Ritamix Global Limited (1936) is a company operating in the animal nutrition and health industry. It engages in the development, manufacture, and distribution of a range of animal feed additives and agricultural products. The company's core offerings include premixes, specialty feed additives, and animal health products, which are designed to enhance livestock productivity and health.

How the Company Makes Money

Ritamix Global Limited generates revenue through the sale of its animal feed additives and health products to agricultural businesses, livestock farms, and distributors. The company's key revenue streams include direct sales of premixes and specialty additives, which are used to improve the nutritional value of animal feed and promote better health outcomes in livestock. Additionally, Ritamix Global may engage in strategic partnerships with agricultural companies and distributors to expand its market reach and product distribution network, thereby contributing to its revenue growth.

Ritamix Global Limited Financial Statement Overview

Summary

Ritamix Global Limited shows financial stability with a strong equity base and low leverage, but faces challenges with declining revenue and margins, as well as volatile cash flows. The company's ability to stabilize cash flow and improve profitability is crucial.

Income Statement

The company's revenue has shown inconsistent growth over the years, with a noticeable decline in 2023. Gross Profit Margin and Net Profit Margin have been relatively stable, but both have decreased in the most recent year. This suggests challenges in maintaining cost efficiency or pricing power. The EBIT and EBITDA margins have also declined, indicating reduced operational profitability.

Balance Sheet

The company maintains a strong equity base with a low Debt-to-Equity Ratio, reflecting solid financial stability and low leverage risk. The Equity Ratio remains robust, further emphasizing the company's reliance on equity financing. However, the Return on Equity has decreased recently, suggesting potential inefficiencies in utilizing shareholder capital.

Cash Flow

The company's free cash flow has been volatile, with a significant drop in the latest period. The absence of operating cash flow in the most recent year is concerning, as it indicates potential issues in generating cash from core operations. This unpredictability poses risks to the company's financial flexibility and ability to fund operations or expansions.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	122.53M	117.80M	134.18M	120.14M	115.88M
Gross Profit	25.77M	26.12M	31.95M	27.91M	26.12M
EBITDA	7.24M	12.43M	18.40M	17.77M	13.89M
Net Income	8.28M	11.42M	11.31M	11.84M	8.45M
Balance Sheet
Total Assets	174.89M	170.51M	159.14M	153.88M	149.02M
Cash, Cash Equivalents and Short-Term Investments	95.07M	88.22M	74.40M	55.00M	68.25M
Total Debt	1.89M	1.88M	87.00K	122.00K	61.00K
Total Liabilities	41.18M	10.35M	10.54M	13.20M	8.31M
Stockholders Equity	134.66M	160.58M	148.60M	140.68M	140.71M
Cash Flow
Free Cash Flow	-2.98M	14.55M	24.08M	3.43M	8.21M
Operating Cash Flow	-274.00K	15.25M	24.79M	4.18M	9.52M
Investing Cash Flow	7.05M	-1.84M	8.22M	6.61M	-50.45M
Financing Cash Flow	-2.91M	-886.00K	-756.00K	-14.30M	49.63M

Ritamix Global Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.58
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1936, the sentiment is Neutral. The current price of 0.58 is above the 20-day moving average (MA) of 0.58, below the 50-day MA of 0.59, and below the 200-day MA of 0.62, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 47.64 is Neutral, neither overbought nor oversold. The STOCH value of 60.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1936.

Ritamix Global Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1431	70 Neutral	HK$1.24B	3.72	6.05%	―	13.36%	―
Sector *	60 Neutral	HK$19.93B	11.90	0.81%	5.34%	2.72%	-47.45%
1432	58 Neutral	HK$2.10B	―	-1.61%	0.92%	-9.24%	-177.19%
1936	55 Neutral	HK$273.76M	19.33	5.56%	―	3.45%	-27.71%
1084	51 Neutral	HK$620.55M	8.92	7.87%	1.67%	-17.35%	―
1117	44 Neutral	HK$8.05B	―	-13.67%	1.30%	-3.39%	-868.11%

Ritamix Global Limited Corporate Events

Ritamix Global Limited Successfully Concludes 2025 AGM with All Resolutions Passed

Ritamix Global Limited announced the successful conclusion of its Annual General Meeting (AGM) held on June 25, 2025, where all proposed resolutions were passed by shareholders. The resolutions included the adoption of financial statements, re-election of directors, and authorization of directors’ remuneration and auditor appointment. The meeting also granted the board mandates to issue and repurchase shares, reflecting strong shareholder support and potentially impacting the company’s future financial strategies and market operations.

Ritamix Global Limited Updates Nomination Committee Terms

Ritamix Global Limited has revised the terms of reference for its Nomination Committee, a key component of its corporate governance structure. The committee, which is responsible for nominating board members, will consist of at least three directors, with a majority being independent non-executive directors, and must include at least one member of a different gender. The revised terms emphasize the committee’s authority to seek information from management and obtain external professional advice, highlighting the company’s commitment to robust governance practices.

Ritamix Global Limited Announces 2025 Annual General Meeting

Ritamix Global Limited has announced its upcoming annual general meeting (AGM) scheduled for June 25, 2025, in Malaysia, with electronic facilitation. The AGM will address several key resolutions, including the adoption of the audited financial statements for 2024, re-election of directors, and re-appointment of the independent auditor. Additionally, the meeting will consider authorizing the board to allot and issue additional shares, which could impact the company’s capital structure and shareholder value.